Ivermectin the Promising Drug to Stave off the COVID-19 Crisis: A Review

Authors

  • Zakia Jahan MPH from the George Washington University, USA. Director of Center for Human Development
  • Masudul Hassan MD in Cardiologist, Professor, & Director, Metropolitan Learning Institute, New York, USA

DOI:

https://doi.org/10.3329/bjid.v7i2.51520

Keywords:

Covid-19; pandemic; Ivermectin.

Abstract

The Coronavirus disease 2019 (COVID-19) outbreak, forcing us to face unprecedented moments in the world. The huge devastating impact of the world due to the covid-19 attack causes the brink of no return. However, there is no proven and specific treatment for Covid -19. Very few medications have received Emergency Use of Authorization. A recent in vitro study was the first time to find out and to assess the antiviral effect of Ivermectin on COVID-19. The study showed that Ivermectin was active against COVID- 19-infected cells, was able to kill effectively almost all viral particles within 48 h. In these moments of crisis, FDA-approved ivermectin is a ray of hope.

Bangladesh Journal of Infectious Diseases 2020;7(2):95-98

Downloads

Download data is not yet available.
Abstract
25
PDF
30

Downloads

Published

2021-01-20

How to Cite

Jahan, Z., & Hassan, M. (2021). Ivermectin the Promising Drug to Stave off the COVID-19 Crisis: A Review. Bangladesh Journal of Infectious Diseases, 7(2), 95–98. https://doi.org/10.3329/bjid.v7i2.51520

Issue

Vol. 7 No. 2 (2020)

Section

Review Articles

License

Copyright

Copyright on any research article in the Bangladesh Journal of Infectious Diseases is retained by the author(s).

The authors grant the Bangladesh Infection Research Association a license to publish the article and identify itself as the original publisher.

Articles in the Bangladesh Journal of Infectious Diseases are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)

This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.